SEC Form 4 · accession 0001450324-16-000008
AIM ImmunoTech Inc. · AIM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas K. Equels
Officer — CEO,Pres,Exec Vice Chairman · Director
Period of report
Mar 11, 2016
Accepted (ET)
Mar 14, 2016 · 8:17 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000946644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 11, 2016 | P | 30,000 | $0.1564 | A | 30,000 | D | |
| Common Stock | Mar 11, 2016 | P | 10,000 | $0.1618 | A | 10,000 | D |
Table II — derivative securities
No Table II lines on this filing.